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Recent sequencing efforts have led to estimates of human cytomeg-
alovirus (HCMV) genome-wide intrahost diversity that rival those of
persistent RNA viruses [Renzette N, Bhattacharjee B, Jensen JD,
Gibson L, Kowalik TF (2011) PLoS Pathog 7:e1001344]. Here, we deep
sequence HCMV genomes recovered from single and longitudinally
collected blood samples from immunocompromised children to show
that the observations of high within-host HCMV nucleotide diversity
are explained by the frequent occurrence of mixed infections caused
by genetically distant strains. To confirm this finding, we recon-
structed within-host viral haplotypes from short-read sequence data.
We verify that within-host HCMV nucleotide diversity in unmixed
infections is no greater than that of other DNA viruses analyzed by
the same sequencing and bioinformatic methods and considerably
less than that of human immunodeficiency and hepatitis C viruses. By
resolving individual viral haplotypes within patients, we reconstruct
the timing, likely origins, and natural history of superinfecting
strains. We uncover evidence for within-host recombination between
genetically distinct HCMV strains, observing the loss of the parental
virus containing the nonrecombinant fragment. The data suggest
selection for strains containing the recombinant fragment, generat-
ing testable hypotheses about HCMV evolution and pathogenesis.
These results highlight that high HCMV diversity present in some
samples is caused by coinfection with multiple distinct strains and
provide reassurance that within the host diversity for single-strain
HCMV infections is no greater than for other herpesviruses.
human cytomegalovirus | diversity | whole genome sequencing |
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HCMV, a geographically ubiquitous human-restricted her-pesvirus, infects 45–100% of the adult population, depending on
age and geographical region (1). Although generally asymptomatic,
HCMV is a significant cause of morbidity and mortality in infants and
patients with primary or acquired immunodeficiency with the po-
tential to cause devastating and life-threatening symptoms including
congenital defects, blindness, and organ transplant failure (1).
Although vaccines are under development, a potential hin-
drance to their efficacy lies in the substantial genetic variability
observed across HCMV genomes, higher than that of any other
human herpesvirus studied. Recent sequencing efforts have also
revealed this heterogeneity may manifest within a single patient,
leading to estimates of genome-wide intrahost diversity that rival
those of persistent RNA viruses, such as HIV and hepatitis C virus
(HCV) (2–6). Somewhat counterintuitively, the elevated diversity
has been attributed to high levels of within-host de novo mutation
(7) despite the low error rates of DNA polymerases (8). More re-
cently, HCMV’s rapid rate of recombination (9) together with the
high prevalence of coinfection with different HCMVs (5) have been
mooted as a more plausible mechanism for variation (2, 3). Dis-
tinguishing diversity that is due to superinfections and/or re-
combination from diversity due to de novo mutation is critical to
understanding intrahost HCMV evolution, particularly in relation
to HCMV compartmentalization and how this impacts on con-
genital and transplant (5) infections as well as for the design of
effective preventative and treatment measures.
Here, we make use of next generation deep sequencing data
derived using the same standardized platforms to compare the
within-host viral diversity of HCMV with nine other DNA and
RNA viral species. Through longitudinal sampling of chronically
HCMV-infected individuals and reconstruction of individual vi-
ral haplotypes, we hypothesize that previous estimates of HCMV
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diversity have been influenced by the presence of multiple strains in a
single sample. We find infections with single strains of HCMV to be
no more diverse within a host than other human herpesviruses and
considerably less variable than chronic RNA viruses, such as HIV
and HCV. By tracking changes in viral population structure over
time, we gain insight into superinfection events, their likely timing,
and observe how recombination in the face of selective forces, such
as drug resistance contribute to HCMV intrahost evolution.
Results
Within-Host Diversity of HCMV Segregates into “Low” and “High”
Populations. Our primary HCMV datasets consisted of 34 sam-
ples collected from eight immune-compromised children over the
course of their infections (set A) as described in Houldcroft et al.
(10) (SI Appendix, Table S1). Genome-wide within-host nucleotide
diversity (π) was calculated for each sample (SI Appendix,Methods).
We found that, on average, observed within-host HCMV diversity
for set A (Fig. 1A) was higher than that of other herpesviruses
[EBV, HSV, and varicella zoster virus (VZV)] (Fig. 1B) but similar
to the diversity seen in 50 samples (set B) collected at a single time
point from both 35 immunosuppressed children and adults (trans-
plant recipients, HIV positive or with primary immunodeficiencies)
and 15 congenitally infected patients (Fig. 1A). In both sets, HCMV
sample diversity separated into higher and lower groups with the
majority demonstrating comparatively low within-host diversity
(Fig. 1A). Separating the samples in set A by patient revealed that
the mean diversity value obtained for the group of eight patients
was inflated by the outlying “high diversity” samples taken from
patients A and D (Fig. 1C). Across all HCMV sample sets A and
B), median genome-wide within-host diversity was calculated to be
0.000306 (9), similar to that observed for other herpesviruses, as
well as previous estimates of HCMV diversity.
Evidence for Mixed HCMV Infections. To determine if the high di-
versity seen in HCMV sequences from patients A and D was the
result of mixed infection or, instead, arose from evolution within the
patient over time, we reconstructed a phylogenetic tree containing
these samples together with highly divergent HCMV strains down-
loaded from GenBank (Fig. 2). We and others have previously
shown that robust whole-genome phylogenies are difficult to obtain
for HCMV given its high propensity for recombination (9, 11). To
circumvent this problem, we chose the 10 kb RL11D region for our
analyses as it had a higher level of linkage disequilibrium, indicating
less recombination, as well as sufficient diversity to resolve distinct
strains (5, 9, 11). We found that, whereas sequences from the first
and final time points from most patients were sister taxa, sequences
from patients A and D were paraphyletic, clustering with high con-
fidence into separate clades (Fig. 2A). Patient B also showed sepa-
ration between the first and the last sequences despite low diversity
(Fig. 1C). The separation of these sequences into distinct clades in-
dicates that the strains present in the final sample from patients A, B,
and D are distinct from those present in the first sample and arose
independently as a result of an additional HCMV infection rather
than evolving from the initial strain within the patient.
To confirm the presence of mixed strains in samples from
patients A, B, and D, we reconstructed whole-genome HCMV
haplotypes from longitudinal sequence data using the newly
developed program HaROLD (haplotype reconstruction of lon-
gitudinal deep-sequencing data) (12). The term haplotype in this
context is used to describe a distinct collection of alleles present
on the same viral genome, arising from a novel mutation on a
preexisting backbone or a phylogenetically distinct cocirculating
viral strain. The number of haplotypes was determined by max-
imizing the logarithmic likelihood, resulting in three haplotypes
for patients A, C, D, E, F, and G and two each for patients B and
H (SI Appendix, Fig. S1). From these reconstructed sequences,
we generated a second RL11 phylogeny. Haplotype sequences
from patients A (A1 and A3), B (B1 and B2), and D (D1 and
D3) clustered with high confidence into separate clades, cor-
roborating the original results (Fig. 2B). For all other samples,
within-patient RL11 patient haplotypes clustered along the same
branch as did haplotypes A1 and A2 from patient A and D1 and
D2 from patient D, suggesting common ancestry or potential
within-host evolution (Fig. 2). To ensure that these findings were
not confined to the RL11 gene complex, we calculated the
maximum pairwise differences between predicted HCMV whole
genome haplotypes for patients A (A1 and A3), B (B1 and B2),
and D (D1 and D3) to be equal to those between unrelated
sequences obtained from GenBank and higher than for pre-
dicted haplotypes in the other patients (SI Appendix, Fig. S2).
Measures of Within-Host Diversity Increase as a Function of Population
Mixture. To understand the timing and course of superinfections
occurring within Patients A, B, and D, we calculated the abundance
of each reconstructed haplotype sequence over time and related this
to sample diversity (Fig. 3). All Patient B samples and the first three
from Patient D showed low diversity, reflecting the predominance
of one haplotype in each sample at nearly 100%. Haplotypes present
at frequencies below 1% (0.1–0.8%) in patients B and D, corre-
sponding to ∼1 read per site, were considered indistinguishable from
noise and were ignored. On this basis, we conclude that Patient B
was initially infected with a single virus B1 and Patient D with two
closely related haplotypes; D2 having evolved from D1. In both
cases, superinfection with a second virus could have occurred. In
Patient B, virus B2 had completely replaced virus B1 by the time of
sampling at day 105, maintaining the low nucleotide diversity (Fig.
3). Although Patient B had received a stem cell transplant at day
80, this was HCMV negative and, therefore, not the source of virus
B2. Instead, HCMV-unscreened blood products administered be-
fore the transplant, in line with clinical policy for transplanted
patients who are themselves already HCMV positive, are a more
likely source (Fig. 3). In Patient D, haplotypes D1 and D2 dis-
appeared, being undetectable by day 175, some 5 mo following a
stem cell transplant (Fig. 3). HCMV viremia was again detected
on day 205 with the new haplotype D3 being the most abundant by
A B C
Fig. 1. Box and whisker plot showing HCMV genome-
wide within-host nucleotide diversity is dichotomous.
(A) Genome-wide intrahost nucleotide diversity in lon-
gitudinal versus single time point HCMV samples. The
circles represent individual samples. The mean values
shown by the horizonal black line, and the median
values shown by the red horizontal line. The box rep-
resents a 25–75% interquartile range. The maximum
and minimum values are represented by vertical lines.
(B) Comparison of HCMV diversity to other herpesvi-
ruses. (C) Nucleotide diversity within eight individual
patients thatmake up the HCMV longitudinal dataset 1.
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the time of sampling at day 300. Again, HCMV-unscreened blood
products may have been the source of virus D3.
In contrast, by the time of the first sample analyzed, Patient A
was already infected with the closely related haplotypes A1 and A2
(95%) and the paraphyletic virus A3 (5%) with A3 replacing A1 to
rise to near fixation by day 190 (Fig. 3). For patients A and D, di-
versity was higher across time points where paraphyletic haplotypes
(A1 and A2 versus A3 and D1 and D2 versus D3) were present at
frequencies of 10% or more being highest when these mixtures
approached 50:50 (Fig. 3). To confirm that nucleotide diversity is
associated with the presence of multiple genetically distinct HCMV
strains present in the same sample, we remapped reads for patients
A and D using the reconstructed haplotype sequences as a refer-
ence. Strikingly, we find that, for both patients A and D, estimates
of nucleotide diversity for individual haplotypes was similar to that
observed for singly infected patients (SI Appendix, Fig. S3).
Haplotype Reconstruction Across the Genome. To examine genome-
wide genetic distance among haplotypes in mixed infections, we
calculated pairwise distances between haplotypes for the different
ORFs. The values obtained were normalized by dividing by the
average pairwise distance observed in the same ORF between un-
related GenBank sequences. We analyzed this distance in Pa-
tients A and D, both of whom had evidence for persisting HCMV
coinfection with distinct haplotypes (Fig. 3). Also, for Patient B, in
whom infection with distinct haplotypes occurred without evidence
of coinfection in the samples tested and Patients C, E, F, and G for
whom there was no evidence of multiple infection (Fig. 4 and SI
Appendix, Fig. S4). For patient H, haplotype H1 was present at low
levels (≤5%) in both samples sequenced with average read depths
of <10 making gene-by-gene sequence comparisons unreliable. The
median relative sequence difference between the two HCMV
haplotypes infecting patient B (B1 and B2) is approximately equal
to that of unrelated GenBank sequences across the whole genome
(Fig. 4). For Patients A and D, the genetic distances between the
phylogenetically distant haplotypes (A1 versus A3 and D1 versus
D3) was also like that seen between unrelated GenBank sequences,
apart from one region in both cases where there was apparent se-
quence identity between otherwise distinct haplotypes (Fig. 4).
Sequences for haplotypes A1 and A3 were almost identical between
A B
Fig. 2. Multiple HCMV infections are present in high-diversity samples. Maximum likelihood phylogenies analysis of the RL11 region from HCMV sequences.
(A) Consensus HCMV sequences taken from the first and last sampling time points from each of the eight patients in the longitudinally samples cohort. (B)
Haplotype sequences reconstructed using longitudinal HCMV samples taken from each patient. GenBank sequences are in gray. Sequences from the same
patients that cluster paraphyletically (A, B, and D) are colored by patient. Patient sequences that cluster monophyletically are in bold black. Topological
robustness was assessed using 1,000 bootstrap replicates. The nodes with black circles represent those with bootstrap scores of >70.









nucleotide positions from 60 and 160 kb, i.e., ORFs UL48–UL112,
and a similar finding was observed for haplotypes D1 and D3 be-
tween 170 and 190 kb (ORFs UL115–UL150A). These results are
most parsimoniously explained by recombination. For patient D,
virus D3 must have recombined with viruses D1/D2 with the loss of
the parental D3 UL115–UL150A region. In the case of patient A
where all three viruses were present in the first sample sequenced,
the recombinant UL48–UL112 sequence was present in the highly
abundant A1 and A2, but there were too few reads to determine
accurately the sequence of this region in A3. By sample 2, all three
A haplotypes were confirmed to be identical in this region within
which lies the DNA polymerase (UL54) and protein kinase (UL97)
genes both of which are targets for antivirals used to treat Patient A
(Fig. 3 and SI Appendix, Fig. S5). Plotting the frequencies of mu-
tations known to confer resistance to the drugs administered as well
as substitutions not known to confer resistance but occurring at
resistance loci (SI Appendix, Fig. S5), provided insight into the pu-
tative role of drug resistance in driving haplotype frequencies and
recombination (SI Appendix, Fig. S5). Haplotypes in Patients C, E,
F, and G, which clustered monophyletically within their respective
hosts, were largely identical across their genomes confirming within
host evolution (SI Appendix, Fig. S4).
HCMV Within-Host Diversity Is Less than That of Chronic RNA Viruses.
Having mapped read data back to haplotypes and corrected for the
presence of mixed infections (SI Appendix, Fig. S3), we calculated the
average genome-wide HCMV within-host nucleotide diversity to be
8.35 × 10−5, which is similar to the mean values observed for other
DNA viruses (Figs. 1 and 5). We found the most outlying samples for
VZV and HSV-1 (Fig. 5, Inset) to contain mixed strain infections,
whereas none of the EBV samples in this study were mixed. Notably,
for HSV-1 and VZV, the mixed outlier samples did not differ from
the mean as much as HCMV, likely due to the lower population-level
variability between strains of these viruses (11). Compared with RNA
viral genomes that had been sequenced and analyzed in the same
pipeline, within-host HCMV diversity was found to be considerably
less than even the least diverse of canonical “hyperdiverse” viruses
including hepatitis B, C, and HIV, with HIV exhibiting the highest
average within-host diversity of any of the viruses tested (Fig. 5).
Discussion
By reconstructing haplotypes from short read sequenced data, we
demonstrate that the most parsimonious explanation for observed
high within-host HCMV diversity is the frequent presence of mixed
infections (Figs. 2 and 3). Making use of a unique collection of
DNA and RNA viruses for which sequencing, quality control,
variant calling, and calculation of nucleotide diversity had been
standardized, we overcome the methodological biases that can ac-
company between-study comparisons (13) to confirm that within-
host diversity of monophyletic HCMV infections is similar to that
seen for other DNA viruses and significantly lower than the mean
diversity of persistent RNA viral infections (Figs. 1 and 5).
Our findings provide some reassurance for the development of
vaccines against HCMV as unlike for hyperdiverse RNA viruses,
vaccine-escape mutations are not likely to occur. Notwithstand-
ing, with mixed infections being common and HCMV having
much greater diversity at the population level than that seen for
other herpesviruses including HSV, VZV, or EBV (11), there
remain significant challenges for the design of effective vaccines
to prevent HCMV infection (14).
The frequency of mixed infection in HCMV infections can be as
high as 61% (15–17), particularly, in the immunocompromised (5,
9, 11) and mixed HCMV infections has been associated with poorer
clinical outcomes (10, 18, 19). Viral recombination, a natural cor-
ollary of mixed infection, is thought to be a major influence on
HCMV pathogenesis, for example, in generating new glycoprotein
B genotypes (20) [promoting viral entry to the cell (21)]. Mecha-
nistic insights into this process, however, have been constrained by
difficulties in deciphering the evolutionary dynamics of individual
viruses within mixed infections. Sequencing methods that generate
haplotype information from long reads are currently too error
prone to give accurate outputs or requiring of too much viral DNA
to work directly on clinical material. Existing computational
methods used for pathogen haplotype reconstruction are largely
designed for highly variable RNA viruses (22, 23) or, based on
cluster analysis and read phasing, exclude too much genetic in-
formation for robust phylogenetic-based analysis (24). Instead, we
used a likelihood-based model to resolve genetically divergent
HCMV haplotypes from short read data and applied it to patients
(A, B, and D) with multiple HCMV infections (12). Haplotypes for
both Patient A and Patient D show long genome-wide genetic
distances and distinct phylogenetic histories that suggest separate
introductions of separate HCMV viruses rather than the evolution
of one haplotype from the other (Fig. 2). Patient B showed com-
plete haplotype (strain) replacement with no evidence of mixed
infection in the samples tested. In contrast, although more than one
HCMV haplotype were supported within Patient C, E, F, G, and H
samples which have low within-host diversity, these are genetically
similar (SI Appendix, Figs. S2 and S3), cluster monophyletically
within a phylogenetic tree (Fig. 2) and are most parsimoniously
explained by within-host evolution of a single strain.
Reconstructing haplotypes from short read data allowed us to
calculate haplotype abundance over time to pinpoint the possibility
that superinfection had occurred and its likely timing and to specu-
late on the origins of superinfecting strains. In Patients B and D, the
superinfection could have originated from HCMV-unscreened blood
transfusions that have been described, albeit rarely, to transmit
HCMV (25, 26) (Fig. 3). Patient D achieved control of his initial
HCMV infection approximately 5 mo following stem cell transplant
with viruses D1 and D2 becoming undetectable by day 175. It is
possible that the superinfection with D3 occurred between day 175
and day 300, the date of the next sample sequenced at a time when
immunosuppression was minimal and T cell recovery well docu-
mented. All three haplotypes, D1, D2, and D3 were present at day
300, raising the possibility that superinfection with virus D3 triggered
the reactivation of viruses D1 and D2 notwithstanding good immune
function. Alternatively, D3 might have been present at undetectable
levels in early samples, becoming detectable only in later samples.
Cocirculation of all three viruses would have promoted the re-
combination observed among D3 and D1/D2. Since ORFs UL128–
UL131 within the recombinant fragment, the code for the pen-
tameric complex, which is required for endo- and epithelial cell
tropisms (27) and UL132–UL150, part of the ULb′ region that is lost
in fibroblast culture (28), contains natural killer immune evasion
genes and chemokine paralogs (UL146/UL147) (29), acquisition
Fig. 3. Haplotype abundances over time for patients A, B, and D with mixed
(paraphyletic) infections. Haplotype frequencies in each sample are shown. The
dark and light blue haplotypes are sister taxa, whereas the yellow haplotypes
are paraphyletic in Fig. 2. The viral load is represented by the black line, and
sample diversity is represented by a horizonal red bar. Antiviral drugs pre-
scribed and their timings are shown in shades of pink and red. The timing of
HSCT and blood products administered to patients B and D are shown.
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of these genes may have altered D3 infectivity, evasion of innate
immunity, and tropism. At the same time, retention of epitopes in
proteins outside the recombinant region would have allowed D3 to
evade the adaptive host immunity that controlled viruses D1 and D2.
In the case of Patient A, haplotype reconstruction provided detailed
insight that allowed us to speculate how recombination, mutation,
and drug selection are likely to have driven the emergence of the
highly resistant A3 virus, which outcompeted viruses A1 and A2 (SI
Appendix, Fig. S5). The results have identified putative drug re-
sistance mutations and provided tools to undertake more detailed
analysis of HCMV control at the molecular level.
To summarize, we show no evidence for high HCMV mutation
rates driving large HCMV diversity over the short evolutionary time-
scale. Instead, we confirm that mixed infection with distinct viral
haplotypes occurs frequently and is the explanation for the observed
high levels of within-patient HCMV diversity. By resolving individual
viral haplotypes within patients, we can reconstruct the likely timing,
origins, and natural history of coinfecting strains to document within-
host recombination and identify putative selection pressures. The
approaches we have taken allow us to generate testable hypotheses
about the factors governing HCMV evolution and pathogenesis in its
natural host and are likely to be important to the rationale use, design,
and impact of preventative and therapeutic interventions in the future.
Methods
Approval for use of anonymized residual diagnostic specimenswere obtained
through the University College London/University College London Hospitals
(UCL/UCLH) Pathogen Biobank National Research Ethics Service Committee
London Fulham (Research Ethics Committee reference: 12/LO/1089). Informed
patient consent was not required. Nucleic acid was enriched using custom
baits and sequenced as previously described (30–36). All sequences were
analyzed by the same methods (SI Appendix). The method used to calculate
Fig. 4. Genome-wide pairwise genetic distance among paraphyletic haplotypes in patients A, B, and D. The blue bars represent genetic distance among ORFs for
paraphyletic haplotypes A1 and A3, B1 and B2, and D1 and D3, normalized for average pairwise distance between unrelated GenBank HCMV sequences (red line).









diversity is given (SI Appendix). The haplotypes were assembled using HaROLD,
a newly developed maximum likelihood method (12) (SI Appendix).
Raw sequencing data for HCMV have been deposited in the European
Nucleotide Archive under project accession no. PRJEB12814.
Raw data for VZV, EBV, HSV, HBV, HCV, HIV, Influenza, and Norovirus
have been deposited as part of other studies.
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Fig. 5. Genome-wide within-host nucleotide diver-
sity across DNA and RNA viruses. The circles represent
individual samples. Mean diversity represented by a
black horizontal line. Median diversity represented
by a red horizontal line. The box represents a 25–75%
interquartile range. The maximum and minimum
values are represented by vertical lines. The number
of samples in each dataset shown above the plot.
The “HCMV (Single+Mixed)” label represents diversity
calculated from all samples mapped to reference,
whereas the “HCMV (Single)” label represents all sam-
ples where reads from patients with mixed infections
were remapped to resolve single-infection diversity.
The circled points represent known mixed infections.
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